{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:14:18Z","timestamp":1788426858442,"version":"build-2803163510"},"reference-count":76,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Genital herpes is a relatively common chronic lower genital tract sexually transmitted infection caused by herpes simplex virus types 1 and 2 (HSV-1 and HSV-2). It is characterized by recurrent, self-limited genital ulcers, and it is the leading cause of genital ulcer disease worldwide (1). The impact of genital herpes on sexual and reproductive health, including the risk of perinatal infection, necessitates a profound understanding of its clinical presentation, diagnosis, treatment, and prevention. This chapter aims to review the critical clinical aspects of HSV in women, emphasizing relevant evidence-based data.<\/jats:p>","DOI":"10.1097\/grf.0000000000000933","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T13:02:31Z","timestamp":1740574951000},"page":"170-179","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Genital Herpes Simplex Virus Infections in Women\u2014A Clinical Update"],"prefix":"10.1097","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-4202","authenticated-orcid":false,"given":"Nir","family":"Meller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"R1-20250516","doi-asserted-by":"crossref","first-page":"e001875","DOI":"10.1136\/bmjgh-2019-001875","article-title":"The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study","volume":"5","author":"Looker","year":"2020","journal-title":"BMJ Glob Health"},{"key":"R2-20250516","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.idc.2023.02.011","article-title":"Genital herpes infection","volume":"37","author":"Van Wagoner","year":"2023","journal-title":"Infect Dis Clin North Am"},{"key":"R3-20250516","doi-asserted-by":"crossref","first-page":"101333","DOI":"10.1016\/j.coviro.2023.101333","article-title":"Colonization of peripheral ganglia by herpes simplex virus type 1 and 2","volume":"60","author":"Kropp","year":"2023","journal-title":"Curr Opin Virol"},{"key":"R4-20250516","doi-asserted-by":"crossref","first-page":"e0214151","DOI":"10.1371\/journal.pone.0214151","article-title":"Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States","volume":"14","author":"Chemaitelly","year":"2019","journal-title":"PLoS One"},{"key":"R5-20250516","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull World Health Organ"},{"key":"R6-20250516","first-page":"1","article-title":"Prevalence of herpes simplex virus type 1 and type 2 in persons aged 14-49: United States, 2015-2016","volume":"304","author":"McQuillan","year":"2018","journal-title":"NCHS Data Brief"},{"key":"R7-20250516","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/OLQ.0000000000000043","article-title":"Trends in seroprevalence of herpes simplex virus type 2 among Non-Hispanic Blacks and Non-Hispanic Whites aged 14 to 49 years\u2014United States, 1988 to 2010","volume":"40","author":"Fanfair","year":"2013","journal-title":"Sex Transm Dis"},{"key":"R9-20250516","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1086\/429622","article-title":"Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization","volume":"40","author":"Cherpes","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R10-20250516","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.aids.0000222078.75867.77","article-title":"Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations","volume":"20","author":"Ameli","year":"2006","journal-title":"AIDS"},{"key":"R11-20250516","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s12160-014-9640-9","article-title":"Psychological distress, emotional stability, and emotion regulation moderate dynamics of herpes simplex virus Type 2 recurrence","volume":"49","author":"Horn","year":"2015","journal-title":"Ann Behav Med"},{"key":"R12-20250516","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.gtc.2013.09.003","article-title":"Sexually transmitted and anorectal infectious diseases","volume":"42","author":"Cone","year":"2013","journal-title":"Gastroenterol Clin North Am"},{"key":"R13-20250516","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00007435-198501000-00007","article-title":"Frequency of acquisition of first-episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts","volume":"12","author":"Merts","year":"1985","journal-title":"Sex Transm Dis"},{"key":"R15-20250516","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.olq.0000151414.64297.46","article-title":"Cunnilingus and vaginal intercourse are risk factors for herpes simplex virus type 1 acquisition in women","volume":"32","author":"Cherpes","year":"2005","journal-title":"Sex Transm Dis"},{"key":"R16-20250516","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention","volume":"98","author":"Corey","year":"1983","journal-title":"Ann Intern Med"},{"key":"R17-20250516","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recommendations and Reports"},{"key":"R18-20250516","doi-asserted-by":"crossref","first-page":"958","DOI":"10.7326\/0003-4819-98-6-958","article-title":"Genital herpes simplex virus infections: clinical manifestations, course, and complications","volume":"98","author":"Corey","year":"1983","journal-title":"Ann Intern Med"},{"key":"R20-20250516","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1086\/514600","article-title":"Herpes simplex viruses","volume":"26","author":"Whitley","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R21-20250516","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.0001-6349.2004.00500.x","article-title":"Transient urinary retention and chronic neuropathic pain associated with genital herpes simplex virus infection","volume":"83","author":"Haanp\u00e4\u00e4","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R22-20250516","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archinte.168.11.1137","article-title":"The Treatment of Herpes Simplex Infections. An Evidence-Based Review","volume":"168","author":"Cernik","year":"2008","journal-title":"Arch Intern Med"},{"key":"R23-20250516","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0002-9343(84)90188-8","article-title":"Serologic analysis of first-episode nonprimary genital herpes simplex virus infection","volume":"77","author":"Bernstein","year":"1984","journal-title":"Am J Med"},{"key":"R24-20250516","doi-asserted-by":"crossref","first-page":"433","DOI":"10.7326\/0003-4819-116-6-433","article-title":"Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes","volume":"116","author":"Koelle","year":"1992","journal-title":"Ann Intern Med"},{"key":"R25-20250516","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00007435-200302000-00015","article-title":"Natural history of genital herpes simplex virus type 1 infection","volume":"30","author":"Engelberg","year":"2003","journal-title":"Sex Transm Dis"},{"key":"R26-20250516","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJM200003233421203","article-title":"Reactivation of genital herpes simplex virus Type 2 infection in asymptomatic seropositive persons","volume":"342","author":"Wald","year":"2000","journal-title":"N Engl J Med"},{"key":"R27-20250516","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy381","article-title":"A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiologya","volume":"67","author":"Miller","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"s5","key":"R28-20250516","doi-asserted-by":"crossref","first-page":"S248","DOI":"10.1086\/422364","article-title":"Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients","volume":"39","author":"Levin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R29-20250516","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2011.08988.x","article-title":"Management of multidrug-resistant viruses in the immunocompromised host","volume":"156","author":"Sellar","year":"2012","journal-title":"Br J Haematol"},{"key":"R30-20250516","doi-asserted-by":"crossref","first-page":"ofae230","DOI":"10.1093\/ofid\/ofae230","article-title":"Summary of the Centers for Disease Control and Prevention\/National Institute of Allergy and Infectious Diseases Joint Workshop on genital herpes: 3\u20134 November 2022","volume":"11","author":"Connolly","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"R31-20250516","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1086\/314900","article-title":"Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed","volume":"180","author":"Schmit","year":"1999","journal-title":"J Infect Dis"},{"key":"R32-20250516","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1111\/ijd.16597","article-title":"Intravenous cidofovir for pseudotumoral genital herpes simplex virus infection in two persons living with human immunodeficiency virus (HIV)","volume":"62","author":"Jumpertz","year":"2023","journal-title":"Int J Dermatol"},{"key":"R33-20250516","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijid.2015.02.002","article-title":"Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study","volume":"33","author":"Leeyaphan","year":"2015","journal-title":"Int J Infect Dis"},{"key":"R34-20250516","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nri888","article-title":"Viruses and interferon: a fight for supremacy","volume":"2","author":"Katze","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"R35-20250516","doi-asserted-by":"crossref","first-page":"1048.e1","DOI":"10.1016\/j.jaad.2010.08.034","article-title":"Topical use of systemic drugs in dermatology: a comprehensive review","volume":"65","author":"Chiu","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R36-20250516","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/tid.12582","article-title":"Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation","volume":"18","author":"Voigt","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"R37-20250516","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.antiviral.2016.08.024","article-title":"Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: a single-center experience","volume":"134","author":"El-Haddad","year":"2016","journal-title":"Antiviral Res"},{"key":"R38-20250516","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1007\/s00520-016-3264-5","article-title":"Complex management of resistant oral herpes simplex virus infection following hematopoietic stem cell transplantation: potential role of topical cidofovir","volume":"24","author":"Epstein","year":"2016","journal-title":"Support Care Cancer"},{"key":"R39-20250516","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJMoa1301150","article-title":"Helicase\u2013primase inhibitor pritelivir for HSV-2 infection","volume":"370","author":"Wald","year":"2014","journal-title":"N Engl J Med"},{"key":"R40-20250516","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.2016.18189","article-title":"Effect of pritelivir compared with valacyclovir on genital HSV-2 shedding in patients with frequent recurrences","volume":"316","author":"Wald","year":"2016","journal-title":"JAMA"},{"issue":"Suppl_2","key":"R41-20250516","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1093\/cid\/ciab1056","article-title":"Diagnosis and management of genital herpes: key questions and review of the evidence for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines","volume":"74","author":"Johnston","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R42-20250516","first-page":"CD009036","article-title":"Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients","volume":"2014","author":"Le Cleach","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"R43-20250516","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1086\/424519","article-title":"Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract","volume":"190","author":"Gupta","year":"2004","journal-title":"J Infect Dis"},{"issue":"5_Part_2","key":"R44-20250516","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-137-5_Part_2-200209031-00002","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20142002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America","volume":"137","author":"Masur","year":"2002","journal-title":"Ann Intern Med"},{"key":"R45-20250516","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/339325","article-title":"Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection","volume":"34","author":"Wald","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R46-20250516","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1071\/SH08013","article-title":"2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study","volume":"5","author":"Bodsworth","year":"2008","journal-title":"Sex Health"},{"key":"R47-20250516","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/OLQ.0b013e31815e4190","article-title":"One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection","volume":"35","author":"Bavaro","year":"2008","journal-title":"Sex Transm Dis"},{"key":"R48-20250516","first-page":"30","article-title":"Short-course therapy for recurrent genital herpes and herpes labialis","volume":"56","author":"Spruance","year":"2007","journal-title":"J Fam Pract"},{"key":"R49-20250516","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/jama.2011.420","article-title":"Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection","volume":"305","author":"Tronstein","year":"2011","journal-title":"JAMA"},{"key":"R50-20250516","first-page":"42","article-title":"Lysine for herpes simplex prophylaxis: a review of the evidence","volume":"16","author":"Mailoo","year":"2017","journal-title":"Integr Med (Encinitas)"},{"key":"R51-20250516","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000248823","article-title":"Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis","volume":"175","author":"Griffith","year":"1987","journal-title":"Dermatologica"},{"key":"R52-20250516","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1984.01650370054010","article-title":"Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis","volume":"120","author":"DiGiovanna","year":"1984","journal-title":"Arch Dermatol"},{"key":"R53-20250516","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1128\/JCM.38.5.1758-1762.2000","article-title":"Zinc salts inactivate clinical isolates of herpes simplex virus in vitro","volume":"38","author":"Arens","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R54-20250516","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0306-9877(85)90142-2","article-title":"Use of topical zinc to prevent recurrent herpes simplex infection: review of literature and suggested protocols","volume":"17","author":"Eby","year":"1985","journal-title":"Med Hypotheses"},{"key":"R55-20250516","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4103\/0253-7184.112867","article-title":"Herpes genitalis - Topical zinc sulfate: an alternative therapeutic and modality","volume":"34","author":"Mahajan","year":"2013","journal-title":"Indian J Sex Transm Dis AIDS"},{"key":"R56-20250516","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0714.2005.00327.x","article-title":"Recurrent herpes labialis: a pilot study of the efficacy of zinc therapy","volume":"34","author":"Femiano","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"R57-20250516","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s12602-017-9320-8","article-title":"Comparison of acyclovir and multistrain lactobacillus brevis in women with recurrent genital herpes infections: a double-blind, randomized, controlled study","volume":"10","author":"Mohseni","year":"2018","journal-title":"Probiotics Antimicrob Proteins"},{"key":"R58-20250516","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cid\/civ908","article-title":"Effect of condom use on per-act HSV-2 transmission risk in HIV-1, HSV-2-discordant couples","volume":"62","author":"Magaret","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R59-20250516","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archinternmed.2009.177","article-title":"A pooled analysis of the effect of condoms in preventing HSV-2 acquisition","volume":"169","author":"Martin","year":"2009","journal-title":"Arch Intern Med"},{"key":"R60-20250516","doi-asserted-by":"crossref","first-page":"e1113","DOI":"10.1016\/S2214-109X(17)30369-8","article-title":"Association between male circumcision and women\u2019s biomedical health outcomes: a systematic review","volume":"5","author":"Grund","year":"2017","journal-title":"Lancet Glob Health"},{"key":"R61-20250516","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa035144","article-title":"Once-daily valacyclovir to reduce the risk of transmission of genital herpes","volume":"350","author":"Corey","year":"2004","journal-title":"N Engl J Med"},{"key":"R62-20250516","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/M13-2471","article-title":"Daily oral tenofovir and emtricitabine\u2013tenofovir preexposure prophylaxis reduces herpes simplex virus type 2 acquisition among heterosexual HIV-1\u2013uninfected men and women","volume":"161","author":"Celum","year":"2014","journal-title":"Ann Intern Med"},{"key":"R63-20250516","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/infdis\/jiz045","article-title":"Tenofovir gel for prevention of herpes simplex virus type 2 acquisition: findings from the VOICE Trial","volume":"219","author":"Marrazzo","year":"2019","journal-title":"J Infect Dis"},{"key":"R64-20250516","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1410649","article-title":"Tenofovir gel for the prevention of herpes simplex virus type 2 infection","volume":"373","author":"Abdool Karim","year":"2015","journal-title":"N Engl J Med"},{"key":"R65-20250516","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiv317","article-title":"Oral and vaginal tenofovir for genital herpes simplex virus type 2 shedding in immunocompetent women: a double-blind, randomized, cross-over trial","volume":"212","author":"Bender Ignacio","year":"2015","journal-title":"J Infect Dis"},{"key":"R66-20250516","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/504717","article-title":"Knowledge of partners\u2019 genital herpes protects against herpes simplex virus type 2 acquisition","volume":"194","author":"Wald","year":"2006","journal-title":"J Infect Dis"},{"key":"R67-20250516","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"R68-20250516","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.4049\/jimmunol.1103706","article-title":"Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T Cell migration via activation of p38-CCAAT\/enhancer-binding protein-\u03b2 pathway","volume":"188","author":"Huang","year":"2012","journal-title":"J Immunol"},{"key":"R69-20250516","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nm.2006","article-title":"Persistence of HIV-1 receptor\u2013positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition","volume":"15","author":"Zhu","year":"2009","journal-title":"Nat Med"},{"key":"R70-20250516","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1093\/infdis\/jit333","article-title":"Daily acyclovir to decrease herpes simplex virus type 2 (HSV-2) transmission from HSV-2\/HIV-1 coinfected persons: a randomized controlled trial","volume":"208","author":"Mujugira","year":"2013","journal-title":"J Infect Dis"},{"key":"R71-20250516","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa0904849","article-title":"Acyclovir and Transmission of HIV-1 from Persons Infected with HIV-1 and HSV-2","volume":"362","author":"Celum","year":"2010","journal-title":"N Engl J Med"},{"key":"R72-20250516","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/422755","article-title":"Frequent reactivation of herpes simplex virus among HIV-1\u2013infected patients treated with highly active antiretroviral therapy","volume":"190","author":"Posavad","year":"2004","journal-title":"J Infect Dis"},{"key":"R73-20250516","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/infdis\/jiv765","article-title":"Transient increase in herpes simplex virus type 2 (HSV-2)\u2013associated genital ulcers following initiation of antiretroviral therapy in HIV\/HSV-2\u2013coinfected individuals","volume":"213","author":"Fife","year":"2016","journal-title":"J Infect Dis"},{"key":"R74-20250516","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/infdis\/jit252","article-title":"Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy","volume":"208","author":"Tobian","year":"2013","journal-title":"J Infect Dis"},{"key":"R75-20250516","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1097\/AOG.0000000000003840","article-title":"Management of genital herpes in pregnancy: ACOG practice bulletinacog practice bulletin, number 220","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R76-20250516","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1016\/j.jogc.2017.04.016","article-title":"No. 208-Guidelines for the management of herpes simplex virus in pregnancy","volume":"39","author":"Money","year":"2017","journal-title":"J Obstet Gynaecol Canada"},{"key":"R77-20250516","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.AOG.0000219749.96274.15","article-title":"Valacyclovir prophylaxis to prevent recurrent herpes at delivery","volume":"108","author":"Sheffield","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R78-20250516","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1155\/S1064744902000054","article-title":"Acyclovir suppression to prevent recurrent genital herpesat delivery","volume":"10","author":"Scott","year":"2002","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R79-20250516","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jama.289.2.203","article-title":"Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant","volume":"289","author":"Brown","year":"2003","journal-title":"JAMA"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T13:02:58Z","timestamp":1747400578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000933","relation":{},"ISSN":["0009-9201","1532-5520"],"issn-type":[{"value":"0009-9201","type":"print"},{"value":"1532-5520","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}